H. Leather

发表

Drug interactions in the hematopoietic stem cell transplant (HSCT) recipient: what every transplanter needs to know

H. Leather, 2004, Bone Marrow Transplantation.

Pharmacokinetic evaluation of the drug interaction between intravenous itraconazole and intravenous tacrolimus or intravenous cyclosporin A in allogeneic hematopoietic stem cell transplant recipients.

J. Wingard, Lili Tian, H. Leather, 2006, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Protocol information provides opportunity for patient safety and quality improvement.

T. George, H. Leather, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Utilization of collaborative practice agreements between physicians and pharmacists as a mechanism to increase capacity to care for hematopoietic stem cell transplant recipients.

J. Bubalo, Casey B. Williams, A. M. Engemann, 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Viral Infections in Patients with Hematological Malignancies

J. Wingard, J. Hiemenz, Jack W. Hsu, 2013 .

Conditioning chemotherapy dose adjustment in obese patients: a review and position statement by the American Society for Blood and Marrow Transplantation practice guideline committee.

M. Perales, J. Wingard, J. Pidala, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Is combination antifungal therapy for invasive aspergillosis a necessity in hematopoietic stem-cell transplant recipients?

J. Wingard, H. Leather, 2006, Current opinion in infectious diseases.

Optimizing autologous stem cell mobilization strategies to improve patient outcomes: consensus guidelines and recommendations.

J. Dipersio, R. Soiffer, R. Negrin, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Treatment of Refractory Acute Leukemia with Timed Sequential Chemotherapy Using Topotecan Followed by Etoposide+Mitoxantrone (T-EM) and Correlation with Topoisomerase II Levels

L. Rimsza, R. Braylan, J. Wingard, 2002, Leukemia & lymphoma.

Late onset of invasive aspergillus infection in bone marrow transplant patients at a university hospital

J. Wingard, P. Mehta, V. Reddy, 2002, Bone Marrow Transplantation.

Comparative cost-effectiveness analysis of voriconazole and fluconazole for prevention of invasive fungal infection in patients receiving allogeneic hematopoietic cell transplants.

J. Kurtzberg, J. Wingard, J. Bolaños-Meade, 2013, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

Busulfan, cyclophosphamide, and etoposide as conditioning for autologous stem cell transplantation in multiple myeloma

J. Wingard, C. Cogle, J. Moreb, 2003, American journal of hematology.

Generic immunosuppressants in hematopoietic cell transplantation.

Ya-Chen Tina Shih, A. Kesselheim, F. Appelbaum, 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Infections following hematopoietic stem cell transplantation.

J. Wingard, H. Leather, 2001, Infectious disease clinics of North America.

Uses of immunoglobulins in the management of infection in oncology patients

H. Leather, 2003 .

A new era of antifungal therapy.

J. Wingard, H. Leather, 2004, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

A new model to predict remission status in AML patients based on day 14 bone marrow biopsy.

M. Norkin, Y. Li, J. Wingard, 2016, Leukemia research.

GM-CSF versus G-CSF: engraftment characteristics, resource utilization, and cost following autologous PBSC transplantation.

J. Wingard, M. Zumberg, H. Leather, 2002, Cytotherapy.

Management of CMV Infections after Bone Marrow Transplantation: A Paradigm Shift

J. Wingard, H. Leather, 2000 .

Pharmacoeconomic analysis of caspofungin versus liposomal amphotericin B as empirical antifungal therapy for neutropenic fever.

W. Gerth, J. Wingard, M. Berger, 2007, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

Evolution, incidence, and susceptibility of bacterial bloodstream isolates from 519 bone marrow transplant patients.

R. Ramphal, J. Wingard, H. Leather, 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Immunosuppressive Agents and Monitoring in Long‐Term Survivors

P. Shaughnessy, H. Leather, 2013 .

New strategies of antifungal therapy in hematopoietic stem cell transplant recipients and patients with hematological malignancies.

J. Wingard, H. Leather, 2006, Blood reviews.

Use of antibacterial prophylaxis in patients with chemotherapy-induced neutropenia

J. Wingard, L. Eldjerou, H. Leather, 2012, Current opinion in hematology.

Performance Characteristics of the Platelia Aspergillus Enzyme Immunoassay for Detection of Aspergillus Galactomannan Antigen in Bronchoalveolar Lavage Fluid

Nina Singh, J. Wingard, L. Wheat, 2008, Clinical and Vaccine Immunology.

Bronchoalveolar Lavage Galactomannan in Diagnosis of Invasive Pulmonary Aspergillosis among Solid-Organ Transplant Recipients

J. Wingard, K. Rand, L. Wheat, 2007, Journal of Clinical Microbiology.

Peripheral blood progenitor cell mobilization for autologous and allogeneic hematopoietic cell transplantation: guidelines from the American Society for Blood and Marrow Transplantation.

M. Perales, M. Mohty, J. Wingard, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Dose modification protocol using intravenous busulfan (Busulfex) and cyclophosphamide followed by autologous or allogeneic peripheral blood stem cell transplantation in patients with hematologic malignancies.

J. Wingard, J. McGuirk, E. Copelan, 2004, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Characteristics of Late Fatal Infections after Allogeneic Hematopoietic Cell Transplantation.

M. Norkin, M. Aljurf, J. Wingard, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Galactomannan testing in bronchoalveolar lavage fluid facilitates the diagnosis of invasive pulmonary aspergillosis in patients with hematologic malignancies and stem cell transplant recipients.

M. Jantz, J. Wingard, L. Wheat, 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Use of Bronchoalveolar Lavage To Detect Galactomannan for Diagnosis of Pulmonary Aspergillosis among Nonimmunocompromised Hosts

J. Wingard, K. Rand, L. Wheat, 2007, Journal of Clinical Microbiology.

Association of mannose-binding lectin levels and invasive fungal disease in hematologic malignancy patients receiving myelosuppressive chemotherapy or allogeneic hematopoietic stem cell transplantation

J. Wingard, M. Sugrue, D. Neal, 2016, Bone Marrow Transplantation.

Bronchoalveolar lavage (BAL) galactomannan in the diagnosis of pulmonary aspergillosis among non-immunocompromised hosts

J. Wingard, K. Rand, L. Wheat, 2007 .

CD34+ chimerism analysis for minimal residual disease monitoring after allogeneic hematopoietic cell transplantation.

M. Norkin, J. Wingard, C. Cogle, 2018, Leukemia research : a Forum for Studies on Leukemia and Normal Hemopoiesis.

B harmacokinetic Evaluation of the Drug Interaction etween Intravenous Itraconazole and Intravenous acrolimus or Intravenous Cyclosporin A in llogeneic Hematopoietic Stem Cell ransplant Recipients

J. Wingard, Lili Tian, H. Leather, 2006 .

Treatment of zygomycosis with posaconazole in a patient with acute myeloid leukemia.

J. Wingard, I. Schmalfuss, H. Leather, 2005, Clinical advances in hematology & oncology : H&O.

Prophylaxis, empirical therapy, or pre-emptive therapy of fungal infections in immunocompromised patients: which is better for whom?

J. Wingard, H. Leather, 2002, Current opinion in infectious diseases.

Randomized, double-blind trial of fluconazole versus voriconazole for prevention of invasive fungal infection after allogeneic hematopoietic cell transplantation.

J. Dipersio, J. Kurtzberg, M. Boeckh, 2010, Blood.

PCR-Based Approach Targeting Mucorales-Specific Gene Family for Diagnosis of Mucormycosis

J. Wingard, D. Stevens, Yiyou Gu, 2018, Journal of Clinical Microbiology.

Results of a Randomized, Double-Blind Trial of Fluconazole (FLU) vs. Voriconazole (VORI) for the Prevention of Invasive Fungal Infections (IFI) in 600 Allogeneic Blood and Marrow Transplant (BMT) Patients.

J. Dipersio, J. Kurtzberg, M. Boeckh, 2007 .

Hematopoietic Stem Cell Transplantation for Multiple Myeloma: Guidelines from the American Society for Blood and Marrow Transplantation.

R. Vij, P. Hari, M. Perales, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Adult Idiopathic Thrombocytopenic Purpura (ITP)

Judith A. Smith, H. Leather, 2009 .

Tandem Autologous Stem Cell Transplantation for Multiple Myeloma Patients Based on Response to Their First Transplant—A Prospective Phase II Study

J. Wingard, Myron N. Chang, C. Cogle, 2014, Clinical Medicine Insights. Oncology.

Pharmacoeconomics of hematopoietic stem cell mobilization: an overview of current evidence and gaps in the literature.

Pieter J. Helmons, N. Chao, J. McCarty, 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Neuralgic amyotrophy following recombinant DNA hepatitis B vaccination.

D. Reutens, J. Dunne, H. Leather, 1990, Muscle & nerve.

238Oral (PO) Valganciclovir (VGC) for preemptive therapy of Cytomegalovirus (CMV) Antigenemia (AG) in hematopoietic stem cell transplant (HSCT) recipients

J. Wingard, H. Leather, C. Meyer, 2003 .

Adequacy of published oncology randomized controlled trials to provide therapeutic details needed for clinical application.

T. George, K. Laplant, H. Leather, 2010, Journal of the National Cancer Institute.

Minimal residual disease by either flow cytometry or cytogenetics prior to an allogeneic hematopoietic stem cell transplant is associated with poor outcome in acute myeloid leukemia

M. Norkin, Y. Li, R. Hromas, 2017, Blood Cancer Journal.

Reduced-intensity conditioning using fludarabine with either antithymocyte globulin and BU, or low-dose TBI allowing allogeneic hematopoietic SCT

J. Schold, J. Wingard, R. Amdur, 2010, Bone Marrow Transplantation.

Severity of Acute GVHD and Associated Healthcare Resource Utilization, Cost and Outcomes.

R. Salloum, J. Wingard, R. Itzler, 2021, Transplantation and cellular therapy.

Hepatotoxicity associated with antifungal therapy after bone marrow transplantation.

J. Wingard, H. Leather, 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

A genomics-informed computational biology platform prospectively predicts treatment responses in AML and MDS patients.

M. Norkin, Subharup Guha, J. Wingard, 2019, Blood advances.

Hematopoietic cell transplantation in 2020: summary of year 2 recommendations of the National Marrow Donor Program's System Capacity Initiative.

A. Bracey, C. Anasetti, R. Champlin, 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Severity of Acute Graft-Versus-Host Disease and Associated Healthcare Resource Utilization, Cost and Outcomes

R. Salloum, J. Wingard, R. Itzler, 2021 .

Infections post transplant Late onset of invasive aspergillus infection in bone marrow transplant patients at a university hospital

J. Wingard, P. Mehta, C. Clancy, 2002 .

Impact of Changes of the 2020 Consensus Definitions of Invasive Aspergillosis on Clinical Trial Design: Unintended Consequences for Prevention Trials?

B. Alexander, D. Denning, J. Wingard, 2021, Open forum infectious diseases.

Minimal residual disease by either flow cytometry or cytogenetics prior to an allogeneic hematopoietic stem cell transplant is associated with poor outcome in acute myeloid leukemia

M. Norkin, Y. Li, R. Hromas, 2017, Blood Cancer Journal.

Applying host disease status biomarkers to therapeutic response monitoring in invasive aspergillosis patients

J. Wingard, M. Sugrue, D. Perlin, 2019, Medical mycology.

Empiric antifungal therapy for the neutropenic patient.

J. Wingard, H. Leather, 2001, Oncology.

Protocol information provides opportunity for patient safety and quality improvement.

T. George, H. Leather, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Performance Characteristics of the Platelia Aspergillus Enzyme Immunoassay for Detection of Aspergillus Galactomannan Antigen in Bronchoalveolar Lavage Fluid

Nina Singh, J. Wingard, L. Wheat, 2008, Clinical and Vaccine Immunology.